Investment Stage

Focus Areas

About Investor

Rebecca Pferdehirt serves as a Partner at Andreessen Horowitz, concentrating her investments on BioTech, Health IT, and Health & Hospital Services companies during Seed, Series A, and Series B stages, with investment ranges typically between $500K and $40.0M. Her professional background as an Investment Partner at one of the world's most prominent venture capital firms demonstrates her expertise in identifying promising ventures within the healthcare technology sector. Pferdehirt has established herself as a key figure in supporting companies developing innovative healthcare solutions. Her investment approach emphasizes companies through multiple funding stages with particular attention to biotechnology and healthcare innovation. Pferdehirt's portfolio reflects her focus on transformative technologies with potential to improve health outcomes and delivery systems.